Ascendis Pharma A/S (ASND)
215.95
-1.37
(-0.63%)
USD |
NASDAQ |
Jan 15, 15:00
Ascendis Pharma SG&A Expense (TTM): 446.44M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Novo Nordisk A/S | 10.84B |
| Evaxion AS | 6.00M |
| DBV Technologies SA | 28.71M |
| Cellectis SA | 19.93M |
| Biodexa Pharmaceuticals Plc | 5.354M |